Trial · NCT00000620
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| First Occurrence of a Major Cardiovascular Event (MCE); Specifically Nonfatal Heart Attack, Nonfatal Stroke, or Cardiovascular Death (Measured Throughout the Study) in the Glycemia Trial. | Glycemia Trial: Intensive Control | 503 | participants | ||
| First Occurrence of a Major Cardiovascular Event (MCE); Specifically Nonfatal Heart Attack, Nonfatal Stroke, or Cardiovascular Death (Measured Throughout the Study) in the Glycemia Trial. | Glycemia Trial: Standard Control | 543 | participants | ||
| Death From Any Cause in the Glycemia Trial. | Glycemia Trial: Intensive Control | 391 | participants | ||
| Death From Any Cause in the Glycemia Trial. | Glycemia Trial: Standard Control | 327 | participants | ||
| First Occurrence of Major Cardiovascular Event (MCE) in the Blood Pressure Trial. | BP Trial: Intensive Control | 208 | participants | ||
| First Occurrence of Major Cardiovascular Event (MCE) in the Blood Pressure Trial. | BP Trial: Standard Control | 237 | participants | ||
| Stroke in the Blood Pressure Trial. | BP Trial: Intensive Control | 36 | participants | ||
| Stroke in the Blood Pressure Trial. | BP Trial: Standard Control | 62 | participants | ||
| First Occurrence of Major Cardiovascular Event (MCE) in the Lipid Trial. | Lipid Trial: Fenofibrate | 291 | participants | ||
| First Occurrence of Major Cardiovascular Event (MCE) in the Lipid Trial. | Lipid Trial: Placebo | 310 | participants | ||
| First Occurrence of MCE or Revascularization or Hospitalization for Congestive Heart Failure (CHF) in Lipid Trial. | Lipid Trial: Fenofibrate | 641 | participants | ||
| First Occurrence of MCE or Revascularization or Hospitalization for Congestive Heart Failure (CHF) in Lipid Trial. | Lipid Trial: Placebo | 667 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00000620/results